MNX-160

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMNX-160
Drug Alias NameLMP-160MNX-160
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsCachexiaDiabetes MellitusPsoriasis +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMacronex +[2] 
Active IndicationsN/A
Inactive IndicationsCachexiaDiabetes MellitusPsoriasis +[7] 

Other Information

ATC CodeN/A
Related LinksN/A